Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,619.50
+117.00 (1.80%)
May 4, 2026, 3:30 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.76 trillion as of May 4, 2026. Its market cap has increased by 22.90% in one year.
Market Cap
1.76T
Enterprise Value
1.73T
Revenue
103.14B
Ranking
n/a
PE Ratio
70.90
Stock Price
6,619.50
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.76T, an increase of 86,230.41%. That is a compound annual growth rate of 33.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.76T | 3.55% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.34T |
| Cipla | 1.06T |
| Mankind Pharma | 927.50B |
| Zydus Lifesciences | 897.46B |
| Aurobindo Pharma | 807.02B |
| Glenmark Pharmaceuticals | 679.06B |
| Alkem Laboratories | 645.65B |
| Laurus Labs | 594.36B |